Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Grapefruit Juice on Edoxaban PK/PD in Healthy Adults
NCT07113054Phase 1Active, not recruiting
- Sponsor
- Hyewon Chung
- Start
- Sep 2025
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of edoxaban in Atrial fibrillation (AFib), deep vein thrombosis (DVT) and pulmonary embolism (PE), sponsored by Hyewon Chung. Primary endpoints: Maximum Plasma Concentration, Area Under the Concentration-Time Curve from Time Zero to Infinity and 3 more. Started Sep 2025; status: active, not recruiting.
02
Drugs
edoxaban
03
Conditions
Atrial fibrillation (AFib)deep vein thrombosis (DVT)pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT07113054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07113054.